Additionally, the 36-month beta value for IRIX is 0.76. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for IRIX is 12.23M and currently, short sellers hold a 2.53% ratio of that float. The average trading volume of IRIX on November 14, 2024 was 24.45K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
IRIX) stock’s latest price update
IRIDEX Corp (NASDAQ: IRIX)’s stock price has soared by 34.04 in relation to previous closing price of 1.41. Nevertheless, the company has seen a gain of 35.00% in its stock price over the last five trading days. globenewswire.com reported 2024-11-04 that MOUNTAIN VIEW, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) — Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the third quarter 2024 and provide a business update after the close of trading on Tuesday, November 12, 2024.
IRIX’s Market Performance
IRIDEX Corp (IRIX) has experienced a 35.00% rise in stock performance for the past week, with a 19.24% rise in the past month, and a 0.00% drop in the past quarter. The volatility ratio for the week is 9.57%, and the volatility levels for the past 30 days are at 6.30% for IRIX. The simple moving average for the past 20 days is 23.43% for IRIX’s stock, with a -16.19% simple moving average for the past 200 days.
Analysts’ Opinion of IRIX
Singular Research gave a rating of “Buy” to IRIX, setting the target price at $11.50 in the report published on January 26th of the previous year.
IRIX Trading at 12.26% from the 50-Day Moving Average
After a stumble in the market that brought IRIX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.22% of loss for the given period.
Volatility was left at 6.30%, however, over the last 30 days, the volatility rate increased by 9.57%, as shares surge +18.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.97% lower at present.
During the last 5 trading sessions, IRIX rose by +35.00%, which changed the moving average for the period of 200-days by -34.38% in comparison to the 20-day moving average, which settled at $1.5313. In addition, IRIDEX Corp saw -32.74% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for IRIX
Current profitability levels for the company are sitting at:
- -0.22 for the present operating margin
- 0.38 for the gross margin
The net margin for IRIDEX Corp stands at -0.23. The total capital return value is set at -0.76. Equity return is now at value -122.71, with -31.84 for asset returns.
Based on IRIDEX Corp (IRIX), the company’s capital structure generated 0.45 points at debt to capital in total, while cash flow to debt ratio is standing at -3.27.
Currently, EBITDA for the company is -7.45 million with net debt to EBITDA at 0.18. When we switch over and look at the enterprise to sales, we see a ratio of 0.61. The receivables turnover for the company is 8.13for trailing twelve months and the total asset turnover is 1.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.55.
Conclusion
In conclusion, IRIDEX Corp (IRIX) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
